Scythian Biosciences is a research and development company committed to finding a solution for the prevention and treatment of concussions and traumatic brain injury (TBI) with its proprietary Cannabinoid (CBD) combination.
Company (IPO / Went public)
100 King Street West
Toronto, M5X 1C9
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)